OKYO Pharma Limited Sponsored ADR OKYO
1.38
0.00
0.00%
as of 25 Sep
- Market cap
- $72.4M
- P/E
- 0.0×
Follow OKYO
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '24 | Mar '25 | Sep '25 | Mar '26 | |
|---|---|---|---|---|---|
Current Ratio |
+7 more quarters Free account |
0.28 | 0.40 | 0.58 | 2.43 |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
0.06% | 0.00% | 4.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | (0.05) | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | (0.46) | 0.00 | (3.39) | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | — | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | — | 0.00 | — | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(0.24) | (1.81) | (1.53) | (5.94) | |
Working Capital |
(7.23) | (5.55) | (3.42) | 12.33 | |
Capital Expenditures |
— | 0.00 | — | (0.01) | |
Net Current Asset Value |
(7.23) | (5.55) | (3.42) | 12.33 | |
| Other line items | |||||
Quick Ratio |
0.28 | 0.40 | 0.58 | 2.43 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
— | 0.00 | — | 0.00 | |
Average Receivables |
1.72 | 1.62 | 0.79 | 0.54 | |
Average Payables |
5.46 | 5.24 | 5.95 | 7.85 | |
Average Assets |
3.57 | 2.77 | 4.92 | 11.26 | |
Average Common Equity |
(2.14) | (2.96) | (2.73) | 3.23 | |
Capex to Sales |
— | 0.00 | — | 0.00 |
Columns are period end dates